health canada semaglutide approves first GLP-1 pill for high-risk type 2 diabetes patients Health Canada Approves Ozempic® (semaglutide

It is classified as an incretin mimetic agent, a class of medications that target the bodys natural hormone-based mechanisms for regulating appetite, metabolism, and weight

Higher concentration formulations sometimes demonstrate different stability profiles than more dilute preparations, though this relationship is not always linear or predictable

Lean Protein Lean proteins help boost GLP-1 and preserve muscle mass, which is crucial when losing weight

doi:10.1111/jnc.13248 33

We are talking absorption rates upwards of 40% nearing 50%

If you are experiencing hair loss while taking a GLP-1 medication, speak with your prescribing doctor and arrange a professional hair and scalp evaluation.